Levetiracetam in Early Psychosis

Clinical trial NCT03129360 · COMPLETED

Trial details

NCT number: NCT03129360
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psychosis Schizophrenia Schizo Affective Disorder Schizophreniform

Start date: 2017-08-18
Primary completion: 2021-11-03
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.